| The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine MI Yilmaz, M Saglam, K Caglar, E Cakir, A Sonmez, T Ozgurtas, A Aydin, ... American Journal of Kidney Diseases 47 (1), 42-50, 2006 | 397 | 2006 |
| Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease M Kanbay, Y Solak, HU Unal, YG Kurt, M Gok, H Cetinkaya, M Karaman, ... International urology and nephrology 46, 1619-1625, 2014 | 322 | 2014 |
| FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, E Demirkaya, ... Kidney international 78 (7), 679-685, 2010 | 237 | 2010 |
| Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin MI Yilmaz, M Saglam, AR Qureshi, JJ Carrero, K Caglar, T Eyileten, ... Nephrology Dialysis Transplantation 23 (5), 1621-1627, 2008 | 190 | 2008 |
| Serum visfatin concentration and endothelial dysfunction in chronic kidney disease MI Yilmaz, M Saglam, JJ Carrero, AR Qureshi, K Caglar, T Eyileten, ... Nephrology dialysis transplantation 23 (3), 959-965, 2008 | 186 | 2008 |
| Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, T Eyileten, K Caglar, ... American journal of kidney diseases 59 (2), 177-185, 2012 | 179 | 2012 |
| Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease MI Yilmaz, D Siriopol, M Saglam, YG Kurt, HU Unal, T Eyileten, M Gok, ... Kidney international 86 (6), 1213-1220, 2014 | 172 | 2014 |
| Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients M Kanbay, MI Yilmaz, M Apetrii, M Saglam, H Yaman, HU Unal, M Gok, ... American journal of nephrology 36 (3), 228-237, 2012 | 165 | 2012 |
| Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients K Caglar, MI Yilmaz, M Saglam, E Cakir, C Acikel, T Eyileten, M Yenicesu, ... Clinical Journal of the American Society of Nephrology 3 (1), 61-68, 2008 | 153 | 2008 |
| Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome MI Yilmaz, A Sonmez, K Caglar, T Celik, M Yenicesu, T Eyileten, C Acikel, ... Nephrology 12 (2), 147-153, 2007 | 148 | 2007 |
| ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease K Caglar, MI Yilmaz, A Sonmez, E Cakir, A Kaya, C Acikel, T Eyileten, ... Kidney international 70 (4), 781-787, 2006 | 148 | 2006 |
| Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes MI Yilmaz, P Stenvinkel, A Sonmez, M Saglam, H Yaman, S Kilic, ... Nephrology dialysis transplantation 26 (11), 3537-3543, 2011 | 140 | 2011 |
| Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease Y Solak, A Gaipov, S Turk, M Kayrak, MI Yilmaz, K Caglar, S Verim, ... The American journal of the medical sciences 347 (2), 118-124, 2014 | 135 | 2014 |
| Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients M Kanbay, D Siriopol, M Saglam, YG Kurt, M Gok, H Cetinkaya, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), E1854-E1861, 2014 | 133 | 2014 |
| Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease MI Yilmaz, A Sonmez, AR Qureshi, M Saglam, P Stenvinkel, H Yaman, ... Clinical Journal of the American Society of Nephrology 6 (7), 1617-1625, 2011 | 130 | 2011 |
| Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes MI Yilmaz, A Sonmez, A Ortiz, M Saglam, S Kilic, T Eyileten, K Caglar, ... Clinical journal of the American Society of Nephrology 6 (4), 785-792, 2011 | 125 | 2011 |
| ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction MI Yilmaz, A Sonmez, M Saglam, AR Qureshi, JJ Carrero, K Caglar, ... Journal of the American Society of Nephrology 19 (2), 388-395, 2008 | 113 | 2008 |
| Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow … MI Yilmaz, JJ Carrero, JL Martín-Ventura, A Sonmez, M Saglam, T Celik, ... Clinical journal of the American Society of Nephrology 5 (7), 1174-1181, 2010 | 95 | 2010 |
| Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria MI Yilmaz, J Axelsson, A Sonmez, JJ Carrero, M Saglam, T Eyileten, ... Clinical Journal of the American Society of Nephrology 4 (3), 535-541, 2009 | 94 | 2009 |
| Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation MI Yilmaz, M Saglam, K Caglar, E Cakir, T Ozgurtas, A Sonmez, ... Transplantation 80 (12), 1660-1666, 2005 | 94 | 2005 |
